"Phospholipid Ethers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Phospholipids which have an alcohol moiety in ethereal linkage with a saturated or unsaturated aliphatic alcohol. They are usually derivatives of phosphoglycerols or phosphatidates. The other two alcohol groups of the glycerol backbone are usually in ester linkage. These compounds are widely distributed in animal tissues.
| Descriptor ID |
D010742
|
| MeSH Number(s) |
D02.033.800.875.875.750 D02.355.460.750 D10.570.755.375.760.400.985
|
| Concept/Terms |
Phospholipid Ethers- Phospholipid Ethers
- Ethers, Phospholipid
- Glycerophosphate Ethers
- Ethers, Glycerophosphate
- Glycerol Phosphate Ethers
- Ethers, Glycerol Phosphate
- Phosphate Ethers, Glycerol
- Ether Phosphatidates
- Phosphatidates, Ether
- Ether Phospholipids
- Phospholipids, Ether
|
Below are MeSH descriptors whose meaning is more general than "Phospholipid Ethers".
Below are MeSH descriptors whose meaning is more specific than "Phospholipid Ethers".
This graph shows the total number of publications written about "Phospholipid Ethers" by people in this website by year, and whether "Phospholipid Ethers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phospholipid Ethers" by people in Profiles.
-
Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis. Nat Commun. 2023 04 17; 14(1):2194.
-
Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE. Clin Immunol. 2019 08; 205:43-48.
-
Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer. Cancer Res. 2018 04 15; 78(8):2052-2064.
-
CD74 interferes with the expression of fas receptor on the surface of lymphoma cells. J Exp Clin Cancer Res. 2014 Oct 10; 33:80.
-
Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron. 2004 Oct 28; 44(3):439-51.
-
Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue. Cell Motil Cytoskeleton. 1999; 43(2):99-113.
-
Platelet-activating factor receptor stimulation disrupts neuronal migration In vitro. J Neurosci. 1998 Jan 01; 18(1):307-18.
-
Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature. 1994 Jan 13; 367(6459):175-9.
-
Preclinical activity of ilmofosine against human tumor colony forming units in vitro. Anticancer Drugs. 1992 Feb; 3(1):43-6.